RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers

The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2011-05, Vol.112 (5), p.1243-1249
1. Verfasser: Ito, Kosei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1249
container_issue 5
container_start_page 1243
container_title Journal of cellular biochemistry
container_volume 112
creator Ito, Kosei
description The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcb.23047
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907169153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>907169153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</originalsourceid><addsrcrecordid>eNp1kEtLAzEUhYMotlYX_gHpTlxMm3dmllq0PkotYrG7kMlkhug0UydTtP_e1D5ceeFy4fCdw-UAcI5gD0GI--867WECqTgAbQQTEVFO6SFoQ0FghAnCLXDi_TuEMEkIPgYtjChnDOM2eHqZjmeka123croqjLO6q1wWtrHRn-Rt4VRpXbEmC-WburKuMb6xQe5q5bSp_Sk4ylXpzdn2dsD07vZ1cB-NnocPg-tRpGnCRJRCBlmKeR6LcJFGKTUxwWkWxyiMgQhzlnFqVMxygzSBmiPCRC6CZLghHXC5yV3U1ecyPCHn1mtTlsqZaullAgXiCWIkkFcbUteV97XJ5aK2c1WvJIJyXZ0M1cnf6gJ7sU1dpnOT7cldVwHob4AvW5rV_0nycXCzi4w2Dusb8713qPpDckEEk2_joZyxEZ1gPJAT8gP_jIXe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>907169153</pqid></control><display><type>article</type><title>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Ito, Kosei</creator><creatorcontrib>Ito, Kosei</creatorcontrib><description>The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>ISSN: 1097-4644</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.23047</identifier><identifier>PMID: 21465522</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Apoptosis - genetics ; BMP ; Cell Adhesion - genetics ; Core Binding Factor Alpha 3 Subunit - genetics ; Core Binding Factor Alpha 3 Subunit - metabolism ; gastrointestinal cancers ; Gastrointestinal Neoplasms - genetics ; Gastrointestinal Neoplasms - metabolism ; Gastrointestinal Neoplasms - pathology ; Helicobacter pylori ; Humans ; Intestinal Mucosa - metabolism ; Mice ; RUNX3 ; Signal Transduction - genetics ; TGF-beta ; Transforming Growth Factor beta - genetics ; Transforming Growth Factor beta - metabolism ; Tumor Suppressor Proteins - genetics ; Tumor Suppressor Proteins - metabolism ; Wnt ; Wnt Proteins - metabolism</subject><ispartof>Journal of cellular biochemistry, 2011-05, Vol.112 (5), p.1243-1249</ispartof><rights>Copyright © 2011 Wiley‐Liss, Inc.</rights><rights>Copyright © 2011 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</citedby><cites>FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.23047$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.23047$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21465522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Kosei</creatorcontrib><title>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Apoptosis - genetics</subject><subject>BMP</subject><subject>Cell Adhesion - genetics</subject><subject>Core Binding Factor Alpha 3 Subunit - genetics</subject><subject>Core Binding Factor Alpha 3 Subunit - metabolism</subject><subject>gastrointestinal cancers</subject><subject>Gastrointestinal Neoplasms - genetics</subject><subject>Gastrointestinal Neoplasms - metabolism</subject><subject>Gastrointestinal Neoplasms - pathology</subject><subject>Helicobacter pylori</subject><subject>Humans</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Mice</subject><subject>RUNX3</subject><subject>Signal Transduction - genetics</subject><subject>TGF-beta</subject><subject>Transforming Growth Factor beta - genetics</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Wnt</subject><subject>Wnt Proteins - metabolism</subject><issn>0730-2312</issn><issn>1097-4644</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtLAzEUhYMotlYX_gHpTlxMm3dmllq0PkotYrG7kMlkhug0UydTtP_e1D5ceeFy4fCdw-UAcI5gD0GI--867WECqTgAbQQTEVFO6SFoQ0FghAnCLXDi_TuEMEkIPgYtjChnDOM2eHqZjmeka123croqjLO6q1wWtrHRn-Rt4VRpXbEmC-WburKuMb6xQe5q5bSp_Sk4ylXpzdn2dsD07vZ1cB-NnocPg-tRpGnCRJRCBlmKeR6LcJFGKTUxwWkWxyiMgQhzlnFqVMxygzSBmiPCRC6CZLghHXC5yV3U1ecyPCHn1mtTlsqZaullAgXiCWIkkFcbUteV97XJ5aK2c1WvJIJyXZ0M1cnf6gJ7sU1dpnOT7cldVwHob4AvW5rV_0nycXCzi4w2Dusb8713qPpDckEEk2_joZyxEZ1gPJAT8gP_jIXe</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Ito, Kosei</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope></search><sort><creationdate>201105</creationdate><title>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</title><author>Ito, Kosei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Apoptosis - genetics</topic><topic>BMP</topic><topic>Cell Adhesion - genetics</topic><topic>Core Binding Factor Alpha 3 Subunit - genetics</topic><topic>Core Binding Factor Alpha 3 Subunit - metabolism</topic><topic>gastrointestinal cancers</topic><topic>Gastrointestinal Neoplasms - genetics</topic><topic>Gastrointestinal Neoplasms - metabolism</topic><topic>Gastrointestinal Neoplasms - pathology</topic><topic>Helicobacter pylori</topic><topic>Humans</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Mice</topic><topic>RUNX3</topic><topic>Signal Transduction - genetics</topic><topic>TGF-beta</topic><topic>Transforming Growth Factor beta - genetics</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Wnt</topic><topic>Wnt Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Kosei</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Kosei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2011-05</date><risdate>2011</risdate><volume>112</volume><issue>5</issue><spage>1243</spage><epage>1249</epage><pages>1243-1249</pages><issn>0730-2312</issn><issn>1097-4644</issn><eissn>1097-4644</eissn><abstract>The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21465522</pmid><doi>10.1002/jcb.23047</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2011-05, Vol.112 (5), p.1243-1249
issn 0730-2312
1097-4644
1097-4644
language eng
recordid cdi_proquest_miscellaneous_907169153
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Animals
Apoptosis - genetics
BMP
Cell Adhesion - genetics
Core Binding Factor Alpha 3 Subunit - genetics
Core Binding Factor Alpha 3 Subunit - metabolism
gastrointestinal cancers
Gastrointestinal Neoplasms - genetics
Gastrointestinal Neoplasms - metabolism
Gastrointestinal Neoplasms - pathology
Helicobacter pylori
Humans
Intestinal Mucosa - metabolism
Mice
RUNX3
Signal Transduction - genetics
TGF-beta
Transforming Growth Factor beta - genetics
Transforming Growth Factor beta - metabolism
Tumor Suppressor Proteins - genetics
Tumor Suppressor Proteins - metabolism
Wnt
Wnt Proteins - metabolism
title RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T04%3A10%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RUNX3%20in%20oncogenic%20and%20anti-oncogenic%20signaling%20in%20gastrointestinal%20cancers&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Ito,%20Kosei&rft.date=2011-05&rft.volume=112&rft.issue=5&rft.spage=1243&rft.epage=1249&rft.pages=1243-1249&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.23047&rft_dat=%3Cproquest_cross%3E907169153%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=907169153&rft_id=info:pmid/21465522&rfr_iscdi=true